Publication | Open Access
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis
269
Citations
31
References
2014
Year
In this phase I study, Lactobacillus GG is safe and well-tolerated in cirrhosis and is associated with a reduction in endotoxemia and dysbiosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1